Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D O Oliver

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
The Quarterly Journal of Medicine|March 1, 1991
Joint and systemic distribution of dialysis amyloidN A Athanasou, D Ayers, A J Rainey, et al.
Lancet (London, England)|June 17, 1989
Subcutaneous erythropoietin and peritoneal dialysisJ M Stevens, C A Strong, D O Oliver, et al.
Clinical Nephrology|August 1, 1977
The significance of vesicoureteric reflux in non-pyelonephritic patients supported by long term hemodialysisM C Bishop, S W Moss, D O Oliver, et al.
Lancet (London, England)|June 18, 1977
Renal transplantation and a positive serological cross-matchP J Morris, D O Oliver, K Williams, et al.
British Medical Journal|April 10, 1976
Effect of bromocriptine on plasma growth hormone and glucose tolerance in chronic renal failureJ A Kanis, J G Ledingham, D O Oliver, et al.
Journal of Clinical Pathology|October 1, 1987
Systemic amyloidosis of beta 2-microglobulin type: a complication of long-term haemodialysisJ M Theaker, A E Raine, A J Rainey, et al.
The Quarterly Journal of Medicine|July 1, 1979
Iron metabolism in haemodialysis patients. A study of the management of iron therapy and overloadR Gokal, P R Millard, D J Weatherall, et al.
British Journal of Haematology|November 1, 1988
Erythroid progenitor cell kinetics in chronic haemodialysis patients responding to treatment with recombinant human erythropoietinC D Reid, J Fidler, D O Oliver, et al.
BMJ (Clinical Research Ed.)|January 21, 1989
Late renal failure due to prostatic outflow obstruction: a preventable diseaseS H Sacks, S A Aparicio, A Bevan, et al.
British Medical Journal (Clinical Research Ed.)|January 26, 1985
Who gets renal bone disease before beginning dialysis?T Cundy, D J Hand, D O Oliver, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
The Quarterly Journal of Medicine|March 1, 1991
Joint and systemic distribution of dialysis amyloidN A Athanasou, D Ayers, A J Rainey, et al.
Lancet (London, England)|June 17, 1989
Subcutaneous erythropoietin and peritoneal dialysisJ M Stevens, C A Strong, D O Oliver, et al.
Clinical Nephrology|August 1, 1977
The significance of vesicoureteric reflux in non-pyelonephritic patients supported by long term hemodialysisM C Bishop, S W Moss, D O Oliver, et al.
Lancet (London, England)|June 18, 1977
Renal transplantation and a positive serological cross-matchP J Morris, D O Oliver, K Williams, et al.
British Medical Journal|April 10, 1976
Effect of bromocriptine on plasma growth hormone and glucose tolerance in chronic renal failureJ A Kanis, J G Ledingham, D O Oliver, et al.
Journal of Clinical Pathology|October 1, 1987
Systemic amyloidosis of beta 2-microglobulin type: a complication of long-term haemodialysisJ M Theaker, A E Raine, A J Rainey, et al.
The Quarterly Journal of Medicine|July 1, 1979
Iron metabolism in haemodialysis patients. A study of the management of iron therapy and overloadR Gokal, P R Millard, D J Weatherall, et al.
British Journal of Haematology|November 1, 1988
Erythroid progenitor cell kinetics in chronic haemodialysis patients responding to treatment with recombinant human erythropoietinC D Reid, J Fidler, D O Oliver, et al.
BMJ (Clinical Research Ed.)|January 21, 1989
Late renal failure due to prostatic outflow obstruction: a preventable diseaseS H Sacks, S A Aparicio, A Bevan, et al.
British Medical Journal (Clinical Research Ed.)|January 26, 1985
Who gets renal bone disease before beginning dialysis?T Cundy, D J Hand, D O Oliver, et al.
Pageof 7